ASCO Updates Patient Guidelines
This special “annual highlights” supplement to Oncology News International is acompilation of major advances in the management of lung cancer during 2004, asreported in ONI. Guest editor Dr. Roy Herbst discusses these advances in clinicalmanagement, with a focus on developments in adjuvant therapy for early disease,targeted therapy, and new chemotherapy findings.
ALEXANDRIA, Virginia-TheAmerican Society of Clinical Oncology(ASCO) has released an updatedpatients' version of the society's clinicalpractice guidelines on the treatmentof unresectable non-small-celllung cancer. The 13-page, evidencebasedpublication, titled "AdvancedLung Cancer Treatment," was developed,based on the latest clinical research,by a multidisciplinary panelled by David G. Pfister, MD. The guideprovides help to patients and theirfamilies in learning more about availabletreatment options.Surgical and medical personnel, radiationoncologists, a pulmonary specialist,and a patient advocate helpeddevelop the guide, which was reviewedand approved by ASCO's Health ServicesResearch Committee, its Boardof Directors, and an external peer reviewgroup. The patient guidelines areavailable at www.plwc.org.
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.
Advancing Thoracic Surgery With Robotics and Video-Assisted Strategies
June 13th 2024"Anything that you can do to leverage technology to minimize the variability in surgery eliminates the skill gap so that novice surgeons may become as technically gifted as the intermediate surgeon or the master surgeon."
